Liver and lymph node metastases of prostate cancer visualized on post-therapy imaging after treatment with 188Re-HEDP

Rev Esp Med Nucl Imagen Mol. 2014 Jan-Feb;33(1):58-9. doi: 10.1016/j.remn.2013.04.003. Epub 2013 May 31.

Authors

F Khalaf¹, A S Dogan², T Haslerud¹, A Sabet¹, H J Biersack¹, S Ezziddin¹

Affiliations

¹ Department of Nuclear Medicine, University Hospital Bonn, Bonn, Germany.
² Department of Nuclear Medicine, Düzce University, School of Medicine, Düzce, Turkey. Electronic address: duzcesintigrafimerkezi@gmail.com.

PMID: 23727275
DOI: 10.1016/j.remn.2013.04.003

No abstract available

Publication types

Case Reports

MeSH terms

Adenocarcinoma / diagnostic imaging
Adenocarcinoma / radiotherapy
Adenocarcinoma / secondary*
Aged
Bone Neoplasms / radiotherapy
Bone Neoplasms / secondary
Etidronic Acid / pharmacokinetics
Etidronic Acid / therapeutic use*
Gastrointestinal Tract / diagnostic imaging
Humans
Liver Neoplasms / diagnostic imaging
Liver Neoplasms / secondary*
Lymphatic Metastasis
Male
Multimodal Imaging
Organometallic Compounds / pharmacokinetics
Organometallic Compounds / therapeutic use*
Prostatic Neoplasms / pathology*
Radiopharmaceuticals / pharmacokinetics
Tissue Distribution
Tomography, Emission-Computed, Single-Photon
Tomography, X-Ray Computed

Substances

Organometallic Compounds
Radiopharmaceuticals
rhenium-186 HEDP
Etidronic Acid